Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1664888

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Attention Deficit Hyperactivity Disorder: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help patients with ADHD access necessary medication.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	202582
answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>We are aware of supply issues affecting medicines used for the management of attention deficit hyperactivity disorder (ADHD). We have issued communications, in the form of a National Patient Safety Alert, to the National Health Service to advise healthcare professionals on management of patients during this time. We continue to work closely with manufacturers to resolve the issues as soon as possible and to ensure patients have continuous access to ADHD medicines in the United Kingdom. We anticipate that the supply disruption will resolve at various dates between October and December 2023.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 16:23:32 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1659784

registered interest
date	11/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Semaglutide
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that off-label prescriptions of Ozempic Semaglutide for weight-loss from private healthcare providers do not create supply shortages for those prescribed Ozempic for diabetes.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	198924
answer	answer is ministerial correction date of answer 14/09/2023 answer text <p>We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient Safety Alert which made it clear that Ozempic, which is solely licensed to treat type 2 diabetes, should only be used for that purpose, and should not be routinely prescribed for weight loss.</p><p>All prescribers, whether employed privately or by the National Health Service, are expected to take account of appropriate national guidance. It is for the responsible clinician to work with their patient and decide on the course of treatment, with the provision of the most clinically appropriate care for the individual always being the primary consideration.</p><p>We have engaged with relevant regulators, and the General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have issued a joint statement stressing the importance of health and care professionals meeting regulatory standards.</p><p>We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for United Kingdom patients, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine while there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.</p> answering member constituency Colchester answering member printed Will Quince question first answered 14/09/2023 10:03:11 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1649973

registered interest
date	04/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nabiximols
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure an (a) adequate and (b) equitable supply of Sativex for people with multiple sclerosis to integrated care boards.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	192400
answer	answer is ministerial correction date of answer 11/07/2023 answer text <p>There are currently no reported supply issues concerning the licensed cannabis-based medicine Sativex. The Department has well-established processes to manage and mitigate medicine supply issues, working closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, Devolved Governments and others operating in the supply chain, to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>The decision on whether to prescribe Sativex must be taken by a specialist clinician on a case-by-case basis and funding of this medicine is subject to local National Health Service decisions.</p><p>On 6 September 2021, NHS England issued a reminder to NHS trusts and commissioners (now integrated care boards) of the National Institute for Health and Care Excellence guidance relating to Sativex and their responsibilities. Data from the NHS Business Services Authority indicates that dispensing of this drug in the community has almost doubled between September 21 (205 items) to March 2023 (402 items), according to the latest available data.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/07/2023 09:59:48 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1643493

registered interest
date	09/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Amyloidosis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what comparative assessment his Department has made of the level of access to Dara-CyBorD in (a) England and (b) Scotland for people diagnosed with AL amyloidosis.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	188756
answer	answer is ministerial correction date of answer 19/06/2023 answer text <p>No specific assessment has been made. The availability of medicines on the National Health Service in Scotland is a matter for the devolved administration. The National Institute for Health and Care Excellence (NICE) is currently developing guidance for the NHS in England on the use of daratumumab plus bortezomib, cyclophosphamide and dexamethasone (Dara-CyBorD) for the treatment of newly diagnosed systemic amyloid light-chain amyloidosis in adults. NICE’s draft recommendations published in December 2022 did not recommend use of Dara-CyBorD and are currently subject to an appeal lodged by the company and Myeloma UK.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/06/2023 16:18:46 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1610607

registered interest
date	14/04/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to assess the long-term health implications of the mixture of Dicyclomine and Doxylamine in the previous pregnancy drug Debendox.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	180740
answer	answer is ministerial correction date of answer 19/04/2023 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) does not plan to assess the long-term health implications of the mixture of Dicyclomine and Doxylamine in the previous pregnancy drug Debendox. This medicine was withdrawn for commercial reasons from the market in the United Kingdom in the early 1980s.</p><p>MHRA remains alert to emerging evidence concerning the safety and efficacy of all medicines, taking action to protect the public when necessary. We encourage anyone to report side effect or adverse reactions to medicines they may have taken, however long ago, via the Yellow Card scheme.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/04/2023 13:33:59 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1566073

registered interest
date	11/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Cooperation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for patient care of (a) levels of communication and (b) information sharing facilities between the NHS in England and health services in the devolved nations.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	121063
answer	answer is ministerial correction date of answer 18/01/2023 answer text <p>At an operational level, there are arrangements in place to support the sharing of information across borders. Organisations share information where appropriate to inform good decision-making, support healthcare and minimise risk to patients.</p><p>Legal routes are available to allow the sharing of health data in the United Kingdom to support individual care and to improve health outcomes. We are working with the devolved administrations to ensure that health and care data can be accessed safely and effectively. We have established an agreed processes to manage cross-border healthcare with Wales for patients who live on the English and Welsh border.</p> answering member constituency Colchester answering member printed Will Quince question first answered 18/01/2023 16:36:32 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1523766

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Records: Disclosure of Information
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the implications for her policies of the practice of limiting the access of patients’ health records between the National Health Services of the devolved Administrations.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	65965
answer	answer is ministerial correction date of answer 09/11/2022 answer text <p>‘Data saves lives: reshaping health and social care with data’ sets out the importance of a United Kingdom-wide data focus to ensure the public have confidence in the health and care system. Legal routes are available to allow the sharing of health data in the UK to support individual care and to improve health outcomes. We are working with the devolved administrations to ensure that health and care data can be accessed safely and effectively.</p> answering member constituency Colchester answering member printed Will Quince question first answered 09/11/2022 13:00:21 answering member 4423 label Biography information for Will Quince previous answer version 27468 answering member constituency Newark answering member printed Robert Jenrick answering member 4320
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1379454

registered interest
date	17/11/2021
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Special Educational Needs: Admissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, if his Department will publish the average wait times for SEN school places as at 17 November 2021.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	76790
answer	answer is ministerial correction date of answer 22/11/2021 answer text <p>The department does not collect information on waiting times for places in special schools.</p><p>Where a local authority identifies that a pupil requires a special school place (through the statutory education, health and care assessment process), they are statutorily required to secure the placement under the Children and Families Act 2014. Local authorities have a duty to arrange suitable education for any pupil of compulsory school age who, because of illness, permanent exclusion or other reasons, would not get a suitable education without such provision. Local authorities are required to keep the sufficiency of special educational provision in their area under review.</p><p>On 27 October 2021, my right hon. Friend, the Chancellor of the Exchequer, announced that an additional £2.6 billion has been made available over the next three years to deliver new places and improve existing provision for pupils with special educational needs and disabilities or who require alternative provision. The government continues to invest in the Free Schools programme, through which 74 special and 50 alternative provision free schools have opened across the country since 2010, with 70 similar projects in the pipeline.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 76791 question first answered 22/11/2021 17:22:26 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1379455

registered interest
date	17/11/2021
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Special Educational Needs: Admissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, what recent assessment his Department has made of the impact of waiting times for places in SEN schools on families.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	76791
answer	answer is ministerial correction date of answer 22/11/2021 answer text <p>The department does not collect information on waiting times for places in special schools.</p><p>Where a local authority identifies that a pupil requires a special school place (through the statutory education, health and care assessment process), they are statutorily required to secure the placement under the Children and Families Act 2014. Local authorities have a duty to arrange suitable education for any pupil of compulsory school age who, because of illness, permanent exclusion or other reasons, would not get a suitable education without such provision. Local authorities are required to keep the sufficiency of special educational provision in their area under review.</p><p>On 27 October 2021, my right hon. Friend, the Chancellor of the Exchequer, announced that an additional £2.6 billion has been made available over the next three years to deliver new places and improve existing provision for pupils with special educational needs and disabilities or who require alternative provision. The government continues to invest in the Free Schools programme, through which 74 special and 50 alternative provision free schools have opened across the country since 2010, with 70 similar projects in the pipeline.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 76790 question first answered 22/11/2021 17:22:26 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle

1245156

registered interest
date	20/10/2020
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Discretionary Housing Payments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, how much in discretionary housing payments was allocated between March and July (a) 2020 and (b) 2019.
tabling member constituency	Brighton, Kemptown
tabling member printed	Lloyd Russell-Moyle
uin	106448
answer	answer is ministerial correction date of answer 23/10/2020 answer text <p>Since 2013 the Department has requested that Local Authorities provide details of their use of Discretionary Housing Payment (DHP) funds. This monitoring information is collected twice yearly; in the middle and at the end of the financial year.</p><p> </p><p>The returns are published on-line, and the information to the end of March 2020 is available here:</p><p> </p><p><a href="https://www.gov.uk/government/publications/use-of-discretionary-housing-payments-financial-year-2019-to-2020/use-of-discretionary-housing-payments-analysis-of-end-of-year-returns-from-local-authorities-april-2019-to-march-2020" target="_blank">https://www.gov.uk/government/publications/use-of-discretionary-housing-payments-financial-year-2019-to-2020/use-of-discretionary-housing-payments-analysis-of-end-of-year-returns-from-local-authorities-april-2019-to-march-2020</a></p><p> </p><p>DHPs for Scotland were devolved from 1 April 2017, information and statistics on the use of DHPs in Scotland are available here: <a href="https://www2.gov.scot/Topics/Statistics/Browse/Social-Welfare/dhp" target="_blank">DHPs in Scotland</a></p> answering member constituency Colchester answering member printed Will Quince question first answered 23/10/2020 13:10:38 answering member 4423 label Biography information for Will Quince
tabling member	4615 label Biography information for Lloyd Russell-Moyle